Veterinary Medicines

Tribovax 10 - in - 1 suspension for injection for cattle and sheep

Not authorised
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium perfringens, type B, beta toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium novyi, toxoid
  • Clostridium septicum, toxoid
  • Tetanus toxoid adsorbed
  • Clostridium sordellii, toxoid
  • Clostridium novyi, type D, toxoid
Download as PDF

Product identification

Medicine name:
Bravoxin 10 suspension for injection for cattle and sheep
Tribovax 10 - in - 1 suspension for injection for cattle and sheep
Active substance:
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium perfringens, type B, beta toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium novyi, toxoid
  • Clostridium septicum, toxoid
  • Tetanus toxoid adsorbed
  • Clostridium sordellii, toxoid
  • Clostridium novyi, type D, toxoid
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type A, alpha toxoid
    0.50
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type B, beta toxoid
    18.20
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type C, beta toxoid
    18.20
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    5.30
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium novyi, toxoid
    3.80
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium septicum, toxoid
    4.60
    international unit(s)
    /
    1.00
    millilitre(s)
  • Tetanus toxoid adsorbed
    4.90
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium sordellii, toxoid
    4.40
    international unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium novyi, type D, toxoid
    17.40
    unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
  • QI04AB01
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • (ID1): 1 Box with 1 Bottle (Low Density PolyEthylene) with 20 millilitre(s) (20 millilitre(s))
  • (ID2): 1 Box with 1 Bottle (Low Density PolyEthylene) with 50 millilitre(s) (50 millilitre(s))
  • (ID3): 1 Box with 1 Bottle (Low Density PolyEthylene) with 100 millilitre(s) (100 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • MSD Animal Health UK Limited
  • Intervet International B.V.
Responsible authority:
  • HPRA
Authorisation number:
  • VPA10996/259/001
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0279/001
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."